<DOC>
	<DOCNO>NCT00137397</DOCNO>
	<brief_summary>The main aim study investigate whether take Tolterodine overactive bladder symptom reduce thickness bladder wall , measure intra-vaginal ultrasound . This help doctor understand whether link change thickness bladder wall progression symptom .</brief_summary>
	<brief_title>A Study Measure Effect Tolterodine Extended Release Thickness Bladder Wall Patients With Overactive Bladder</brief_title>
	<detailed_description />
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Tolterodine Tartrate</mesh_term>
	<criteria>Symptoms overactive bladder ( describe urinary urgency , without urge incontinence , usually frequency nocturia 6 month Bladder wall thickness 5mm Treatment previous four week anticholinergic drug drug treatment overactive bladder . Significant stress incontinence Urinary tract infection history intermittent urinary tract infection ( four episode last two year ) . Conditions consider significant investigator ( e.g . cystocoele , significant bladder prolapse , bladder stone , indwell catheter etc )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2006</verification_date>
</DOC>